In vivo chimeric antigen receptor (CAR)-T cell therapy
1. 系统已在2025-10-11 18:54:30对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://doi.org/10.1038/s41573-025-01291-5
其他信息:
A Bot, A Scharenberg, K Friedman, L Guey…
Nature Reviews Drug …, 2025
nature.com
Chimeric antigen receptor (CAR)-T cell therapy has transformed the outcomes of patients with haematological malignancies, yet its use is limited by labour-intensive manufacturing, constrained production capacity and variable clinical performance. In vivo CAR-T cell engineering, in which CAR-T cells are generated directly inside the patient's body, seeks to overcome these challenges by eliminating the need for ex vivo cell processing and complex logistics, as well as improve clinical performance. Recent advances in virology, RNA …
